Skip to content
The Nexus
DossierENTITY

Dr. Aradhana Sarin

Coverage of Dr. Aradhana Sarin in the Nexus archive.

Earliest in view: Jun 5 · 21:20 UTCMost recent: Jul 28 · 10:39 UTC
Co-mentioned in this coverage
AstraZenecaorganization2Chinese pharmaceutical companiesorganization1GLP-1 drugstopic1colorectal cancertopic1Endometrial cancertopic1Pascal Soriotperson1pharma out-licensingtopic1revenue growth goalstopic1
Recent coverage
  • BUSINESSJul 28 · 10:39 UTCSEMAFOR
    China’s up-and-coming pharma giants

    Chinese pharmaceutical companies are advancing in early-stage research and clinical trials but remain about a decade behind global leaders like AstraZeneca. AstraZeneca's CFO, Aradhana Sarin, noted that Chinese firms lack the capability for global clinical trials but may challenge Western competitors within 10 years. The rise of GLP-1 drugs for weight loss could reshape pharmaceutical strategies and cancer prevalence patterns.

  • BUSINESSJun 5 · 21:20 UTCQUARTZ
    AstraZeneca CFO Dr. Aradhana Sarin breaks down revenue growth goals

    Dr. Aradhana Sarin, CFO of AstraZeneca, outlines the company's revenue growth goals.